Analysis of Sampling Bias in Large Health Care Claims Databases-Reference-Cited by-同舟云学术

Analysis of Sampling Bias in Large Health Care Claims Databases

Published:2023-01-06 Issue:1 Volume:6 Page:e2249804
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Dahlen Alex¹,Charu Vivek¹²

Affiliation:

1. Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, California

2. Department of Pathology, Stanford University School of Medicine, Stanford, California

Abstract

This cross-sectional study characterizes variation in sampling in a large health care claims database at the zip code level in 2018 and assesses whether socioeconomic and demographic factors are associated with inclusion.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2800118/dahlen_2023_ld_220294_1671719835.63693.pdf

Reference6 articles.

1. Trends in Utilization of Prescribed Controlled Substances in US Commercially Insured Adults, 2004-2019.;Bykov;JAMA Intern Med,2020

2. Racial/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation.;Eberly;JAMA Netw Open,2021

3. The social determinants of health: it’s time to consider the causes of the causes.;Braveman;Public Health Rep,2014

4. Key considerations when using health insurance claims data in advanced data analyses: an experience report.;Konrad,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost burden of cirrhosis and liver disease progression in metabolic dysfunction–associated steatohepatitis: A US cohort study;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Computational Approaches to Drug Repurposing: Methods, Challenges, and Opportunities;Annual Review of Biomedical Data Science;2024-08-23

3. Benchmarking commercial healthcare claims data;2024-08-20

4. Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea;Toxins;2024-08-17

5. Patient Characteristics and Real-World Use of Botulinum Toxins for the Treatment of Cervical Dystonia, Blepharospasm, and Hemifacial Spasm;Toxins;2024-08-16